Predicting Differences in Treatment Response and Survival Time of Lung Adenocarcinoma Patients Based on a Prognostic Risk Model of Glycolysis-Related Genes

Background: Multiple factors influence the survival of patients with lung adenocarcinoma (LUAD). Specifically, the therapeutic outcomes of treatments and the probability of recurrence of the disease differ among patients with the same stage of LUAD. Therefore, effective prognostic predictors need to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Rongchang, Ding, Dan, Ding, Yan, Han, Rongbo, Wang, Xiujuan, Zhu, Chunrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174756/
https://www.ncbi.nlm.nih.gov/pubmed/35692818
http://dx.doi.org/10.3389/fgene.2022.828543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174756/
https://www.ncbi.nlm.nih.gov/pubmed/35692818
http://dx.doi.org/10.3389/fgene.2022.828543

Ejemplares similares